Statement of Changes in Beneficial Ownership (4)
April 17 2014 - 5:26PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cvijic Christine Mikail
|
2. Issuer Name
and
Ticker or Trading Symbol
NPS PHARMACEUTICALS INC
[
NPSP
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
SVP, Legal Affairs & GC
|
(Last)
(First)
(Middle)
550 HILLS DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/15/2014
|
(Street)
BEDMINSTER, NJ 07921
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (right to buy)
|
$23.38
|
4/15/2014
|
|
A
|
|
79453
|
|
(1)
|
4/15/2024
|
Common Stock
|
79453
|
$0
|
79453
|
D
|
|
Restricted Stock Units
|
(2)
|
4/15/2014
|
|
A
|
|
29085
|
|
(3)
|
(3)
|
Common Stock
|
29085
|
$0
|
29085
|
D
|
|
Explanation of Responses:
|
(
1)
|
The option vests over four years as follows: (i) 25% on the first anniversary of the stock option grant date and (ii) 6.25% on each quarterly anniversary thereafter.
|
(
2)
|
Each restricted stock unit represents a contingent right to receive one share of NPS Pharmaceuticals, Inc.'s common stock.
|
(
3)
|
The restricted stock units vest equally over three years as follows: (i) one-third on the first anniversary of the restricted stock unit grant date, (ii) one-third on the second anniversary of the restricted stock unit grant date and (iii) the remaining one-third on the third anniversary of the restricted stock unit grant date. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the restricted stock units.
|
Remarks:
Exhibit List Exhibit 24 - Power of Attorney
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Cvijic Christine Mikail
550 HILLS DRIVE
BEDMINSTER, NJ 07921
|
|
|
SVP, Legal Affairs & GC
|
|
Signatures
|
/s/ Christine Mikail
|
|
4/17/2014
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Oct 2023 to Oct 2024